NASDAQ:MENS Jyong Biotech (MENS) Stock Price, News & Analysis $2.15 +0.13 (+6.16%) Closing price 03:59 PM EasternExtended Trading$2.19 +0.04 (+1.62%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOwnershipSEC FilingsShort Interest About Jyong Biotech Stock (NASDAQ:MENS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jyong Biotech alerts:Sign Up Key Stats Today's Range$2.05▼$2.1850-Day Range$1.97▼$2.4352-Week Range$1.43▼$63.00Volume21,154 shsAverage Volume164,104 shsMarket Capitalization$163.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jyong Biotech Limited is a clinical-stage biopharmaceutical company focused on developing and commercializing botanical drug products. The company’s research is centered on plant-derived therapies for urological conditions, including disorders affecting the prostate and urinary system. Its product development activities have primarily targeted benign prostatic hyperplasia (BPH), a noncancerous enlargement of the prostate that can cause urinary symptoms, as well as other prostate-related conditions. Jyong Biotech’s portfolio includes botanical drug candidates and related products intended to address unmet needs in urological care. The company is headquartered in China and conducts its research and development activities there. Jyong Biotech is listed on the Nasdaq Capital Market under the symbol MENS. Publicly available information provides limited detail about its broader geographic operations and executive leadership.AI Generated. May Contain Errors. Read More Receive MENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jyong Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MENS Stock News HeadlinesJyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal RoadshowSeptember 3, 2026 | globenewswire.comJyong Biotech Ltd. Ordinary Shares (MENS)July 29, 2026 | nasdaq.comThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, and Millennium by 122%. Kopernik Global made it their largest holding, owning roughly 8% of the company. It holds rights to an 88 million ounce deposit with existing roads, power, and permits that never expire. Market cap sits near $4 billion against a deposit worth hundreds of billions at current gold prices.October 2 at 1:00 AM | Behind the Markets (Ad)Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing PartnershipsJuly 23, 2026 | globenewswire.comJyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International ConventionJuly 2, 2026 | globenewswire.comJyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live InterviewMay 29, 2026 | globenewswire.comJyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year Ended December 31, 2025May 15, 2026 | quiverquant.comQJyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025May 15, 2026 | globenewswire.comSee More Headlines MENS Stock Analysis - Frequently Asked Questions How have MENS shares performed this year? Jyong Biotech's stock was trading at $3.95 at the beginning of the year. Since then, MENS shares have decreased by 46.2% and is now trading at $2.1250. When did Jyong Biotech IPO? Jyong Biotech (MENS) raised $21 million in an initial public offering on Tuesday, June 17th 2025. The company issued 2,666,667 shares at a price of $7.50-$8.50 per share. How do I buy shares of Jyong Biotech? Shares of MENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/02/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:MENS Previous SymbolNASDAQ:MENS CIK1954488 Webwww.jyongbio.com Phone(8862) 27325205FaxN/AEmployees27Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-6.50Miscellaneous Outstanding Shares76,030,000Free FloatN/AMarket Cap$163.01 million OptionableN/A Beta2.39 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:MENS) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredMy next big call (under $1)Crypto traders have a name for this month... Uptober. Since 2013, Bitcoin has closed October higher in 10 of 1...Crypto 101 Media | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jyong Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jyong Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MENS Stock Alerts